Table 3.
Recommendation | Indication | References |
---|---|---|
SCT in CR1 | Benefit demonstrated for matched related donor SCT for Philadelphia chromosome + only. |
Wheeler 2000 [155] |
Chessells 1992 [166] | ||
Not recommended for other high-risk patients, except in the setting of a clinical trial. |
Arico 2000 [11] | |
Uderzo 1997 [156] | ||
SCT in CR2 with prior bone marrow relapse |
Recommended for those with matched related donors. |
Barrett 1994 [51] |
Wheeler 1998 [164] | ||
Evidence insufficient to recommend unrelated donor SCT. |
Uderzo 1995 [162] | |
Harrison 2000 [165] |